Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004977199 | SCV005578456 | uncertain significance | Inborn genetic diseases | 2024-07-30 | criteria provided, single submitter | clinical testing | The c.5126A>T (p.Q1709L) alteration is located in exon 24 (coding exon 24) of the DNAH9 gene. This alteration results from a A to T substitution at nucleotide position 5126, causing the glutamine (Q) at amino acid position 1709 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |